Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma

Bone Marrow Transplant. 2005 Jul;36(1):89-90. doi: 10.1038/sj.bmt.1705002.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Bone and Bones / metabolism
  • Disease-Free Survival
  • Etidronic Acid / pharmacokinetics
  • Etidronic Acid / therapeutic use*
  • Humans
  • Melphalan / therapeutic use*
  • Middle Aged
  • Multiple Myeloma / therapy*
  • Myeloablative Agonists / therapeutic use
  • Organometallic Compounds / pharmacokinetics
  • Organometallic Compounds / therapeutic use*
  • Peripheral Blood Stem Cell Transplantation / methods*
  • Radioisotopes / therapeutic use
  • Remission Induction / methods
  • Rhenium / therapeutic use
  • Salvage Therapy / methods
  • Transplantation, Autologous

Substances

  • Myeloablative Agonists
  • Organometallic Compounds
  • Radioisotopes
  • rhenium-186 HEDP
  • Rhenium
  • Etidronic Acid
  • Melphalan